WebJan 9, 2024 · AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled hypertension as well as chronic kidney disease. The acquisition will bolster AstraZeneca’s cardiorenal pipeline by adding … WebToday we announced an agreement to acquire CinCor Pharma, Inc., a US-based clinical-stage biopharmaceutical company, focused on developing …
CinCor Pharma Raises $143 Million in Series B Financing
Webcincor pharma, inc. 1,665 followers on linkedin. developing the next generation of treatments for cardio-renal diseases. developing the next generation of treatments for cardiovascular diseases. WebCinCor Pharma, Inc. 2,885 followers on LinkedIn. DEVELOPING THE NEXT GENERATION OF TREATMENTS FOR CARDIO-RENAL DISEASES. DEVELOPING … how do you use writing to learn
CinCor Hypertension Drug Flunks Study, But the Biotech Still Sees …
WebCinCor Pharma Inc. said Monday that the Phase 2 trial of its hypertension treatment baxdrostat did not meet its primary endpoint, sending shares 34% lower to $17.49 in premarket trading. WebOct 12, 2024 · CinCor Pharma, Inc. (“CinCor”) today announced the completion of a $143 million Series B financing. The proceeds from this round will support the continued development of CIN-107, a highly selective, oral small molecule inhibitor of aldosterone synthase product candidate in development for the treatment of hypertension, primary … WebDina Chaya is a Partner at Omega Funds. She has been investing in the private equity and venture capital healthcare industry in Europe and the … how do you use xtool creative space